<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02579993</url>
  </required_header>
  <id_info>
    <org_study_id>CI-051-2014</org_study_id>
    <nct_id>NCT02579993</nct_id>
  </id_info>
  <brief_title>ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation</brief_title>
  <official_title>ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation Expanded in Vitro on Amniotic Membrane in Patients With Limbal Stem Cell Deficiency.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Oftalmología Fundación Conde de Valenciana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Council of Science and Technology, Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto de Oftalmología Fundación Conde de Valenciana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the prognostic value of ABCB5 in survival of the limbal stem cell
      transplantation expanded in vitro on amniotic membrane for corneal surface reconstruction in
      patients with limbal stem cell deficiency will be analyzed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are several diseases that cause the cornea to lose its clarity and directly affects the
      vision of the individual, therefore, the use of limbal stem cells has been having increasing
      acceptance in the field of medical therapy. An open clinical study is running with patients
      with limbal stem cell deficiency, performing a limbal stem cell transplantation expanded in
      vitro on amniotic membrane and the value of ABCB5 as a prognostic factor in the survival of
      transplant will be determined. The corneal surface status will be the primary endpoint.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Preliminar results not favorable
  </why_stopped>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Objective clinical evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>A grading system from 0 to 4 using photographs taken with slit lamp, will be used to determine by two independent examiners the degree of corneal transparency and superficial vascularization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective clinical evaluation</measure>
    <time_frame>12 months</time_frame>
    <description>A grading system from 0 to 4 using photographs taken with slit lamp, will be used to determine by two independent examiners the degree of corneal transparency and superficial vascularization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Corneal cells morphology</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of the presence of epithelial, conjunctival or mixed cells with in vivo confocal microscopy and impression cytology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal cells morphology</measure>
    <time_frame>12 months</time_frame>
    <description>Evaluation of the presence of epithelial, conjunctival or mixed cells with in vivo confocal microscopy and impression cytology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>Modified National Eye Institute Visual Function Questionnaire 25 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>Modified National Eye Institute Visual Function Questionnaire 25 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>6 months</time_frame>
    <description>Visual acuity in the Logarithm of the Minimum Angle of Resolution scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>12 months</time_frame>
    <description>Visual acuity in the Logarithm of the Minimum Angle of Resolution scale</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Limbal Stem Cell Deficiency</condition>
  <arm_group>
    <arm_group_label>Stem Cell Transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cultivated Limbal Stem Cell Transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pannus and conjunctival dissection</intervention_name>
    <description>A complete conjunctival peritomy is performed and the fibrovascular pannus and conjunctiva invading the cornea is dissected from the cornea and limbus.</description>
    <arm_group_label>Stem Cell Transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Human cultivated limbal stem cell transplantation</intervention_name>
    <description>The amniotic membrane graft cultured with the human limbal stem cell transplantation is placed in the limbic and corneal surface and fixed with fibrin glue. The amniotic membrane is placed with the stroma in contact with the graft and it is sutured.</description>
    <arm_group_label>Stem Cell Transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Bilateral limbal stem cell deficiency of any etiology.

          2. Corneal impression cytology positive for goblet cells.

          3. Ocular ultrasound results within normal parameters.

          4. Agree to participate in the study and sign the informed consent.

        Exclusion Criteria:

        1. Active immunological diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yonathan Garfias, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Instituto de Oftalmologia Conde de Valenciana</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto de Oftalmologia Conde de Valenciana</name>
      <address>
        <city>Mexico City</city>
        <zip>06800</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2015</study_first_submitted>
  <study_first_submitted_qc>October 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2015</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cornea</keyword>
  <keyword>Limbal stem cell</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

